News

Medical equipment maker West Pharmaceutical raised its annual profit forecast on Thursday, after topping second-quarter estimates on robust demand for its components used in GLP-1 weight-loss and ...
Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...
Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...
Novo Nordisk faces challenges in the competitive GLP-1 market, but its strong brand and R&D create opportunities for ...
ANI Pharmaceuticals (ANIP) stock drops as its Iluvien implant fails in a clinical trial versus Eylea marketed by Regeneron ...
MEI Pharma has taken a major step, becoming the first publicly traded firm on a national exchange to include Litecoin (LTC) as a major treasury reserve asset. Starting with a $100 million private ...
In ANI's New Day trial, patients were randomized to an induction phase to receive either a single Iluvien injection or a series of five monthly injections of aflibercept, followed by supplemental ...
The site in Lexington focuses on drug research and development and the manufacturing of sterile injectable products.
Aphena Pharma Solutions is a full range packaging and manufacturing service provider in the pharmaceutical (OTC, Rx), medical device, and biologics industries. With our continued investment in ...
Tmunity Therapeutics, with ties to Penn Medicine, once raised $231 million from investors. Now workers and its Center City office are gone.